Ms. Scharen-Guivel has served on our Board since 2022. Ms. Scharen-Guivel joined NeuroEM Therapeutics Medical & Scientific Advisory Board in March 2026 and currently serves on the Board of Trustees of St. Anthony s Hospital, part of the community-owned Baycare Health System since January 2025. She has been serving on St. Anthony s Clinical Excellence Committee since February 2025 and recently joined Baycare Medical Group (BMG) Board of Trustees since January 2026. From January 2022 to present, Ms. Scharen-Guivel serves on the Tampa Bay Technology Incubator (TBTI) Council of Professionals, and Guest Speaker to the University of South Florida ( USF ) and USF Connect. Ms. Scharen-Guivel served as Program Director of the U.S. Food and Drug Administration (the FDA ) Center of Devices and Radiological Health from 2017 to 2022, where she led and implemented the new Medical Device Development Tools program. Her career spans over 25 years within multiple federal agencies, including the FDA, the Department of Health and Human Services, and the National Institutes of Health. She retired from active duty as a Captain of the United States Public Health Service in 2022. Ms. Scharen-Guivel received a B.S. in Biomedical Engineering and a Master s Degree in Engineering from the Catholic University of America. We believe that Ms. Scharen-Guivel s experience and expertise in the fields of FDA medical product regulatory strategy, policy and risk qualify her to serve on our Board.